Patents
Sitemap › C07 - Organic chemistry › C07H - Sugars; Derivatives thereof; Nucleosides; Nucleotides; Nucleic acids › C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892)
10/1996
10/22/1996US5567688 L-nucleosides for the treatment of hepatitis B-virus
10/22/1996US5567687 Useful in photodynamic therapy and light-induced cleavage of a polymer of deoxyribonucleic acid
10/22/1996US5567604 Anti-viral guanosine-rich oligonucleotides
10/22/1996US5567588 Forming nucleic acid-target complexes; partitioning increased affinity nucleic acids; amplification
10/22/1996CA1338663C Biosynthetic osteogenic proteins and osteogenic devices containing them
10/17/1996WO1996032504A2 Solid phase sequencing of biopolymers
10/17/1996WO1996032496A2 Covalently linked oligonucleotide minor groove binder conjugates
10/17/1996WO1996032495A1 Monoclonal antibody specific for human 4-1bb and cell line producing same
10/17/1996WO1996027006A3 Human vegf-specific antisense oligonucleotides
10/17/1996WO1996017951A3 Identification of genes responsible for in vivo survival of microorganisms
10/17/1996WO1996016084A3 A method of identifying cftr-binding compounds useful for activating chloride conductance in animal cells
10/17/1996CA2218188A1 Solid phase sequencing of biopolymers
10/16/1996EP0737750A2 Expression of exogenous polynucleotide sequences in a vertebrate
10/16/1996EP0737747A2 Cytoplasmatic expression in E. coli of antibodies, antibody fragments and fusions thereof
10/16/1996EP0737251A1 Antibodies to egf receptor and their antitumour effect
10/16/1996EP0737249A1 Tumor suppressor protein prb2, related gene products, and dna encoding therefor
10/16/1996EP0737248A1 Gene expression control
10/16/1996EP0737247A1 Method and reagent for inhibiting hepatitis c virus replication
10/16/1996EP0737232A1 Modular design and synthesis of aminimide containing molecules
10/16/1996EP0737201A1 Backbone modified oligonucleotide analogs and solid phase synthesis thereof
10/16/1996EP0737085A1 VACCINE FOR $i(BRANHAMELLA CATARRHALIS)
10/16/1996EP0737076A1 Method for antigen-specific immunoregulation by t-cell alpha chain
10/16/1996EP0737075A1 Ileal bile acid transporter compositions and methods
10/16/1996EP0737071A1 Anti-sense oligodeoxynucleotide to fibrogenic cytokines and use thereof
10/16/1996CN1133616A A novel nuclear mitotic phosphoprotein:mitosin
10/16/1996CN1133599A Recombinant IL4 antibodies useful in treatment of IL4 mediated disorders
10/16/1996CN1133595A Mutants of the Rb and P53 genes and uses thereof
10/16/1996CN1133594A Hsv-2 UL26 gene, capsid proteins, immunoassays and protease inhibitors
10/15/1996US5565570 Chemiluminescent acridinium salts
10/15/1996US5565552 Method of expanded porphyrin-oligonucleotide conjugate synthesis
10/15/1996US5565438 L-nucleosides for the treatment of epstein-bar virus
10/15/1996US5565362 DNA sequences to target proteins to the mammary gland for efficient secretion
10/15/1996US5565350 Compounds and methods for site directed mutations in eukaryotic cells
10/15/1996US5565336 Nucleic acid molecule which codes a human interleukin mutein with increased activity and having a phenylalanine residue at position 171 replaced by leucine and a leucine residue at position 175 replaced by methionine
10/15/1996US5565324 Complex combinatorial chemical libraries encoded with tags
10/15/1996US5565322 Hybridization of polynucleotides conjugated with chromophores and fluorophores to generate donor-to donor energy transfer system
10/15/1996US5565321 Isolating nucleic acid, amplifying nucleic acid derived from cd40 ligand gene, determining nucleotide sequence, comparing to standard, determining if protein is expressed which binds cd40
10/10/1996WO1996031623A1 Polynucleotides for detecting leishmanias and method of detection of leishmanial protozoa
10/10/1996WO1996031618A1 ISOLATED FrpB NUCLEIC ACID MOLECULE AND VACCINE
10/10/1996WO1996031523A1 Covalently cross-linked oligonucleotides, method for preparing same, and synthon used therein
10/10/1996WO1996001430A3 Screening for nuc inhibitors
10/09/1996EP0736602A2 Siaalpha 2,3Ga1beta 1, 4G1cNAc alpha 2,8-sialyltransferase
10/09/1996EP0736601A2 Non-A, non-B, non-C, non-D, non-E hepatitis reagents and methods for their use
10/09/1996EP0736105A1 Systematic evolution of ligands by exponential enrichment: photoselection of nucleic acid ligands and solution selex
10/09/1996EP0736103A1 Nucleotide-directed assembly of bimolecular and multimolecular drugs and devices
10/09/1996EP0736095A1 Human circulating cytokine cc-1
10/09/1996EP0736094A1 Polycystic kidney disease 1 gene and uses thereof
10/09/1996EP0736093A1 ANTISENSE NUCLEIC ACIDS FOR THE PREVENTION AND TREATMENT OF DISORDERS IN WHICH EXPRESSION OF c-erbB PLAYS A ROLE
10/09/1996EP0736034A1 Dna encoding the wnt-x growth factor
10/09/1996EP0736002A1 Compound capable of introducing at least one molecule into a cell
10/09/1996EP0735899A1 Synthetic oligomers having phosphonate internucleosidyl linkages of undefined chirality mixed with non-phosphonate internucleosidyl linkages
10/09/1996EP0735891A1 A 46 Kd HUMAN MILK FAT GLOBULE ANTIGEN
10/09/1996EP0735889A1 A novel tumor suppressor gene
10/09/1996EP0735818A1 MACROPHAGE INFLAMMATORY PROTEINS-3, -4 AND -1 Sg(g)
10/09/1996EP0594578B1 Oligoribonucleoside and oligodeoxyribonucleoside boranophosphates
10/09/1996CN1133063A DNA Molecule encoding for cellular uptake of mycobacterium tuberculosis
10/09/1996CN1133049A Melanona-inhibiting protein
10/08/1996US5563255 Antisense oligonucleotide modulation of raf gene expression
10/08/1996US5563253 Linear aminoalkylphosphoramidate oligonucleotide derivatives
10/08/1996US5563055 Method of Agrobacterium-mediated transformation of cultured soybean cells
10/08/1996US5563050 Herpes virus
10/08/1996US5563048 Human stromal derived factor 1α and 1β, and DNAs encoding the same
10/07/1996CA2170073A1 Non-a, non-b, non-c, non-d, non-e hepatitis reagents and methods for their use
10/03/1996WO1996030525A1 BARLEY β-AMYLASE STRUCTURAL GENE
10/03/1996WO1996030406A1 Human g-protein coupled receptors
10/03/1996WO1996030386A1 Amidite derivatives and oligonucleotide derivatives
10/03/1996WO1996030384A1 Single-stranded circular oligonucleotides
10/03/1996WO1996030383A1 Nucleic acid polyester polyamides
10/03/1996WO1996022373A3 Monoclonal antibody 1a7 and use for the treatment of melanoma and small cell carcinoma
10/03/1996CA2216844A1 Amidite derivatives and oligonucleotide derivatives
10/02/1996EP0735365A2 DNA base sequencer
10/02/1996EP0735046A1 Oligonucleotide and carcinostatic agent containing the same as active ingredient
10/02/1996EP0734451A1 ENTEROTOXINS OF $i(SHIGELLA FLEXNERI) 2a
10/02/1996EP0734448A1 Gene therapy for restenosis using an adenoviral vector
10/02/1996EP0734442A1 Diagnosis of metastatic cancer by the mts-1 gene
10/02/1996EP0734439A1 p53-BINDING POLYPEPTIDES AND POLYNUCLEOTIDES ENCODING SAME
10/02/1996EP0734436A1 Inhibition of dna methyltransferase
10/02/1996EP0734397A1 Apparatus and method for polymer synthesis using arrays
10/02/1996EP0734391A1 Pna-dna-pna chimeric macromolecules
10/02/1996EP0653943A4 Targeting somatic gene therapy to joints.
10/02/1996CN1132529A DNA sequencing enzymes
10/02/1996CN1132251A Pencillin V. Amidohydrrolase gene from fusarium oxysporum
10/01/1996US5561225 Phosphorus-free nucleotides, oligonucleotides and polynucleotides having sulfonate or sulfonamide linkages; antisense agents; anticarcinogenic agents; parasiticides; genetic probes; hiv
10/01/1996US5561071 DNA and DNA technology for the construction of networks to be used in chip construction and chip production (DNA-chips)
10/01/1996US5561043 Genetic engineering
10/01/1996CA1338619C Lectin complex and method and probe for making same
09/1996
09/26/1996WO1996029338A1 Identification of gene mutations associated with congenital lipoid adrenal hyperplasia
09/26/1996WO1996029337A1 Thiono triester modified antisense oligodeoxynucleotide phosphorothioates
09/26/1996WO1996029097A1 Stem-loop and circular oligonucleotides
09/26/1996WO1996023065A3 Inhibition of neovascularization using vegf-specific oligonucleotides
09/26/1996CA2216284A1 Thiono triester modified antisense oligodeoxynucleotide phosphorothioates
09/26/1996CA2215825A1 Stem-loop and circular oligonucleotides
09/25/1996EP0733905A2 System for nucleic acid based diagnostic assay
09/25/1996EP0733714A2 Nucleic acid amplification method and apparatus
09/25/1996EP0733713A1 Procedure for measuring the transcription - regulatory activities of DNA-sequences
09/25/1996EP0733711A2 Method for cloning and producing the SacI restriction endonuclease
09/25/1996EP0733709A2 Mutated farnesyldiphosphate synthase capable of synthesizing geranylgeranyldiphosphate and gene coding therefor
09/25/1996EP0733707A2 Gene participating in the mechanism of secretion of esterase
09/25/1996EP0733704A2 Controlable expression system
09/25/1996EP0733206A1 Labelling of nucleic acid analogue-peptide chimerae
1 ... 816 817 818 819 820 821 822 823 824 825 826 827 828 829 830 831 832 833 834 835 836 ... 899